The animal nutrition industry is evolving rapidly as producers face growing demands for productivity, sustainability, animal welfare, and reduced reliance on antibiotics. From global feed manufacturers and integrated agribusinesses to specialized players in enzymes, probiotics, amino acids, and precision nutrition, companies are investing in science, technology, and strategic expansion to address these changing needs.
This report highlights 20 prominent animal nutrition companies of 2026, selected based on industry visibility, portfolio breadth, global footprint, innovation activity, sustainability relevance, and corporate scale. It provides a snapshot of each company’s business, nutrition portfolio, market relevance, and recent strategic developments, offering a view of the companies helping shape the next generation of animal nutrition.
1. Cargill
Category: Global Integrated Major
Quick Facts
- Founded: 1865
- Headquarters: Minnetonka/Wayzata, Minnesota, United States
- Total Employees: ~155,000–160,000 worldwide
- Ownership: Private (Cargill-MacMillan family, ~88%)
- Species/Segment Focus: Poultry, swine, ruminant, aquaculture, companion animal (via micronutrition and pet food)
Overview
Cargill is one of the world’s largest privately held companies and a foundational player in global animal nutrition, operating across the global food supply chain including grain trading and processing, animal nutrition, meat and poultry production, and food ingredients, in 70 countries serving 125 markets worldwide. Its Animal Nutrition & Health division sits within this broader agribusiness empire, giving it unmatched raw-material integration from farm to feed.
Portfolio & Relevance
Cargill’s nutrition portfolio spans precision and micronutrition solutions, with its Micronutrition and Health Solutions (MHS) business including branded lines like Biostrong™, designed to enhance digestive health and optimize growth in poultry, improving feed conversion ratio by reducing feed consumption while increasing chicken weight. The company maintains dedicated animal nutrition leadership (Cargill Animal Nutrition and Health) with regional structures across Asia-Pacific, South America, and Europe.
Recent Development (2025)
Cargill has been especially active in 2025: it completed a major expansion at its Engerwitzdorf, Austria facility, increasing micronutrition production capacity by 50% to meet growing customer demand, formalized a strategic partnership with Cooperl for the China market via a Memorandum of Understanding at VIV Asia 2025, and moved to expand its animal nutrition business in Brazil through an acquisition strengthening its position in the country’s swine production sector. It also extended into companion-animal nutrition science, launching PetMaster’s first non-staple product enriched with immune postbiotics at CIIE 2025 in China
2. ADM (Archer Daniels Midland)
Category: Global Integrated Major
Quick Facts
- Founded: 1902
- Headquarters: Chicago, Illinois, United States
- Total Employees: ~42,000 worldwide
- Ownership: Public (NYSE: ADM)
- Species/Segment Focus: Poultry, swine, ruminant, aquaculture, companion animal (via feed and premix)
Overview
ADM is one of the world’s largest agricultural processors, operating through four segments, Ag Services and Oilseeds, Carbohydrate Solutions, Nutrition, and Other, with the Nutrition segment serving food, beverage, nutritional supplement, and feed and premix markets for livestock, aquaculture, and pet food. Its scale in grain origination and processing gives its animal nutrition business direct upstream access to raw ingredients most competitors have to buy in.
Portfolio & Relevance
ADM has been steadily building out a dedicated feed-science portfolio beyond commodity ingredients. It has introduced a non-starch polysaccharide (NSP) enzyme line developed specifically for poultry and swine, reflecting a push into functional, performance-based additives rather than pure bulk feed supply. The company has also expanded its microbial and probiotics capability through R&D partnerships and lab investments, positioning its Nutrition segment as a genuine science-driven competitor to the additive specialists on this list, not just a commodity supplier.
Recent Development (2025–2026)
ADM has moved aggressively into functional and precision nutrition over the past year. In December 2025, ADM Animal Nutrition advanced development of customized poultry premixes targeting antibiotic-free and sustainable production systems, with formulations emphasizing gut health and growth consistency. That followed a broader February 2026 move where ADM announced expansion of its premix and feed ingredient manufacturing facilities in Europe, focused on micronutrient fortification and precision formulation technologies for dairy and aquaculture applications. These sit alongside ADM’s longer-running probiotics push, including its earlier acquisition of Biopolis for microbial technologies and subsequent R&D partnerships in prebiotics, probiotics, and animal health enzymes, which continues to feed innovation into its animal nutrition portfolio
3. New Hope Group
Category: Global Integrated Major
Quick Facts
- Founded: 1982 (Liu Yonghao and brothers); New Hope Liuhe listed 1998
- Headquarters: Chengdu, Sichuan, China
- Total Employees: ~40,000–70,000 (group-wide estimates vary by source)
- Ownership: Private group; New Hope Liuhe subsidiary publicly listed (Shenzhen Stock Exchange)
- Species/Segment Focus: Poultry, swine (breeding, farming, and feed), with growing dairy and food operations
Overview
New Hope Group has grown into the world’s largest animal feed manufacturer by production volume, alongside becoming one of China’s largest integrated suppliers of meat, eggs, and dairy products, with over 600 subsidiaries and nearly 100,000 employees. Its core subsidiary, New Hope Liuhe, is China’s largest feed manufacturer, operating across China and 30 other countries, primarily in Asia.
Portfolio & Relevance
The group’s scale is staggering by volume: in 2025, New Hope Liuhe achieved sales revenue of RMB 106.9 billion, with annual feed sales of 29.74 million tons, from over 240 feed mills, and produced 17.55 million pigs. This makes it the clearest example on this list of feed production at true industrial scale, a vertically integrated model spanning feed manufacturing, livestock breeding, and slaughter/processing.
Recent Development (2025)
New Hope’s founder Liu Yonghao spoke at a February 2025 symposium for private enterprises in Beijing, emphasizing the group’s continued focus on agriculture, animal husbandry, and food amid consumption structure adjustments and cyclical market impacts, a signal of the group navigating China’s volatile hog cycle while maintaining its position as the country’s top feed producer. Its international footprint continues to expand through subsidiaries and joint ventures across Vietnam, the Philippines, Indonesia, Singapore, and Egypt.
4. Charoen Pokphand Group (CP Foods)
Category: Global Integrated Major
Quick Facts
- Founded: 1921 (CP Group); Charoen Pokphand Foods (CPF) established 1978
- Headquarters: Bangkok, Thailand
- Total Employees: ~74,000 (CPF); 450,000+ across the wider CP Group
- Ownership: Public (CPF, SET: CPF); majority-owned by the private Chearavanont family’s CP Group
- Species/Segment Focus: Poultry, swine, aquaculture (shrimp and fish)
Overview
CP Foods is the agricultural arm of the broader Charoen Pokphand conglomerate and one of the world’s largest producers of animal feed and shrimp, and a global top-three producer of poultry and pork. Its business is fully vertically integrated, covering the entire cycle from sourcing raw materials for animal feed production, manufacturing feed, breeding and farming animals, to meat processing and distribution to domestic and international consumers.
Portfolio & Relevance
CP Foods reported total sales revenue of 580,747 million Thai baht in 2024, with international operations contributing over 60% of revenue, reflecting its expansion well beyond its Thai home base into markets across Asia, Europe, and the Americas. Its dual focus on livestock (chicken, duck, pig) and aquaculture (shrimp, fish) gives it a broader species footprint than most livestock-only feed majors.
Recent Development (2025)
CPF continued strategic joint-venture activity into late 2025, including a CPF NH Foods joint venture deal finalized October 29, 2025, extending its integrated food and protein production partnerships. The company has also been active on sustainability commitments across its supply chain, part of its broader push into plant-based and alternative protein lines (e.g., its earlier MEAT ZERO launch) alongside its core feed and livestock business.
5. Nutreco (Trouw Nutrition)
Category: Global Integrated Major
Quick Facts
- Founded: 1994 (as Nutreco); Trouw and Skretting brands have 100+ years of individual heritage
- Headquarters: Amersfoort, Netherlands
- Total Employees: ~11,000 across 35+ countries
- Ownership: Private (wholly owned by SHV Holdings since 2015)
- Species/Segment Focus: Livestock (via Trouw Nutrition) and aquaculture (via Skretting), poultry, swine, ruminant, fish, shrimp
Overview
Nutreco operates through two business lines: Skretting, a world leader in aquaculture feed manufacturing, and Trouw Nutrition, a global leader in feed specialties, premixes, and nutritional services for livestock, giving it one of the most balanced livestock/aquaculture portfolios among the global majors. It maintains over 100 production facilities and 11 R&D centers focused on sustainable nutrition innovation.
Portfolio & Relevance
Nutreco’s R&D output is a key differentiator: Trouw Nutrition’s research facilities welcome nearly 5,000 visitors annually and conduct more than 70 global R&D studies on topics including new molecules, modes of action, ingredient properties, and animal metabolism. Its dedicated innovation arm, NuFrontiers (launched 2018), and Skretting’s “Garden of the Future” facility (opened 2024) both reflect heavy investment in next-generation, plant-based nutritional technology. Nutreco
Recent Development (2025)
In November 2025, Nutreco and Skretting launched the first phytotechnology-based products for fish and shrimp, incorporating EDGEOS Phyto-Complexes, plant metabolites designed to strengthen resilience, performance, and welfare in farm animals, developed through the company’s Nutreco Exploration innovation unit. On sustainability, Nutreco’s 2025 Impact Report showed the company achieved a 47% reduction in scope 1 and 2 greenhouse gas emissions versus its 2018 baseline and eliminated coal and oil use across its operations, reinforcing its relevance in the industry’s low-carbon feed conversation
6. De Heus
Category: Global Integrated Major
Quick Facts
- Founded: 1911 (family-owned; over a century of operation)
- Headquarters: Ede, Netherlands
- Total Employees: Not publicly disclosed at group level; large multinational workforce across 80+ countries
- Ownership: Private, family-owned (De Heus family)
- Species/Segment Focus: Poultry, swine, ruminant (dairy), and aquaculture
Overview
De Heus is an international producer of a complete range of compound feed, premixes, concentrates and feed specialties, serving independent farmers, integrations, and dealers with a hands-on advisory model, its specialists visit thousands of farms worldwide, offering nutritional strategy advice alongside product supply. Having been a family-managed business for 100 years, De Heus continues to be led by the De Heus family, with Gabor Fluit taking over as CEO on January 1, 2025.
Portfolio & Relevance
De Heus has distinguished itself through aggressive emerging-market expansion rather than competing head-on with Cargill and Nutreco in mature Western markets, building out feed mills across Africa, Southeast Asia, and South Asia, with dedicated dairy, swine, and poultry offerings tailored to each region’s farming conditions.
Recent Development (2025)
2025 was an active expansion year: De Heus opened a new fish feed factory in Njeru, Uganda in September 2025, marking a significant milestone for East Africa’s aquaculture sector after entering the Ugandan market in 2015. The company also transitioned to a one-tier board governance model effective January 1, 2025, and continued its acquisition strategy in Asia, having completed the acquisition of CJ Feed & Care, marking a significant expansion in the region.
7. ForFarmers
Category: Global Integrated Major
Quick Facts
- Founded: 1896
- Headquarters: Lochem, Netherlands
- Total Employees: ~2,900–2,963
- Ownership: Public (Euronext Amsterdam: FFARM)
- Species/Segment Focus: Ruminant (dairy), poultry, swine — primarily European livestock
Overview
ForFarmers is a leading European feed player offering complete feed solutions for (organic) livestock farming, with production operations in the Netherlands (head office), Germany, Poland, and the UK, exporting to countries within and outside Europe. With sales of around 10 million tonnes of animal feed, it’s the clearest large-scale, publicly listed pure-play feed company on this list, giving readers a transparent look at sector financials most peers keep private.
Portfolio & Relevance
Its 2025 results underscore genuine operational strength rather than just scale: a record year with 10.6 million tonnes of feed sold and underlying net profit up 52.5% to €61.9 million, with ROACE on underlying EBIT rising to 17.4%. CEO Pieter Wolleswinkel attributed the results to market share gains, particularly in the Netherlands, alongside favorable raw material and selling price conditions.
Recent Development (2025)
ForFarmers made several strategic moves through the year, including strengthening the Dutch poultry value chain through investment in a broiler farm and the acquisition of Beukelaar Diervoeders, largely completing integration of its Van Triest acquisition, and progressing its German joint venture with team agrar. Most notably, it announced an intended joint venture with KPS Food Group to significantly strengthen its position in the growing Polish market.
8. Wilmar International
Category: Global Integrated Major (diversified agribusiness with feed operations)
Quick Facts
- Founded: 1991
- Headquarters: Singapore
- Total Employees: ~100,000 across the group
- Ownership: Public (SGX-listed)
- Species/Segment Focus: Livestock feed as part of a broader Feed & Industrial Products segment (also includes oleochemicals, biodiesel)
Overview
As noted earlier, Wilmar is Asia’s leading integrated agribusiness group, spanning the entire agricultural commodity value chain from cultivation and milling to processing, branding, and distribution, with over 1,000 manufacturing plants across China, India, Indonesia, and 50+ other countries. Animal feed sits within its Feed & Industrial Products segment, alongside non-edible palm/lauric products, oleochemicals, and biodiesel, reflecting Wilmar’s identity as a diversified commodity processor rather than a nutrition specialist.
Portfolio & Relevance
The scale is nonetheless real: Feed and Industrial Products sales volume reached 67,975 thousand metric tonnes in FY2025. Wilmar’s most direct animal-nutrition-specific brand presence remains the Volac Wilmar Feed Ingredients joint venture, focused on rumen-protected feed fats for the dairy sector.
Recent Development (2025)
FY2025 was a strong year for this segment specifically: the Feed and Industrial Products segment recorded a 4% increase in pre-tax profit to US driven by higher crushing margins and improved sugar merchandising contributions. Group-wide, Wilmar reported FY2025 revenue 70.42 billion, up 4.5% year-on-year, with net profit rising 20.6% to US$1.41 billion, and management specifically noted feed and industrial segment volumes increased around 3-5% year-on-year, aided by livestock demand and efficient supply chains
9. Evonik (Animal Nutrition)
Category: Feed Additive & Ingredient Specialist
Quick Facts
- Founded: Evonik formed 2007 (from RAG-Stiftung restructuring); Animal Nutrition business line has 60+ years of amino acid production heritage
- Headquarters: Essen, Germany
- Total Employees: Evonik group-wide ~33,000; Animal Nutrition division not separately disclosed
- Ownership: Public (Frankfurt Stock Exchange: EVK)
- Species/Segment Focus: Poultry, swine, ruminant, amino acids, probiotics, functional feed additives
Overview
Evonik is a global chemical company headquartered in Essen, Germany, active in more than 100 countries, generating group sales of €14.1 billion and adjusted EBITDA of €1.9 billion in 2025. Its Animal Nutrition business line has more than 60 years of experience producing essential amino acids, offering solutions for efficient and sustainable animal nutrition to customers in more than 100 countries. It’s one of the most tenured names on this list, with amino acid science as its core identity rather than a diversified side business. EvonikEvonik
Portfolio & Relevance
Evonik’s flagship products are its amino acids, MetAMINO® (DL-methionine), unrivaled in bioefficacy and purity exceeding 99%, and Biolys® (L-lysine), both cornerstones of poultry and swine nutrition strategies that help producers optimize protein efficiency, reduce feed costs, and minimize environmental impact. Beyond amino acids, the company has built out a functional additive portfolio including probiotics and plant-based immune modulators, plus digital feed-quality services like AMINONIR® (NIR-based analytical service), AMINODat® (a global nutrition database), and AMINOSpec® (dynamic feeding programs).
Recent Development (2025–2026)
Evonik has stayed highly visible on the trade-show circuit. In November 2025, it showcased an enhanced version of its Ecobiol® probiotic at Poultry India 2025, featuring a Bacillus CECT 5940-based formulation that germinates up to 46% faster than competitor products, alongside its amino acid and specialty additive lines. The company is also marking 50 years of exhibiting at IPPE in January 2026, with a continued focus on amino acids, gut health, and feed quality services, a notable milestone underscoring its long-standing presence in the industry. On sustainability, Evonik notes MetAMINO®’s product carbon footprint is approximately 35% lower than the calculated global industry average, a data point that ties directly into the low-carbon feed narrative shaping the sector.
10. BASF (Animal Nutrition)
Category: Feed Additive & Ingredient Specialist
Quick Facts
- Founded: BASF (group) founded 1865; Animal Nutrition business built on decades of vitamin/carotenoid production heritage
- Headquarters: Ludwigshafen am Rhein, Germany
- Total Employees: BASF group ~112,000 worldwide; Animal Nutrition division not separately disclosed at scale
- Ownership: Public (Frankfurt Stock Exchange: BAS)
- Species/Segment Focus: Poultry, swine, ruminant, aquaculture, companion animal, vitamins, carotenoids, enzymes, organic acids, trace elements
Overview
BASF Animal Nutrition draws on the parent company’s century-plus chemical manufacturing scale, positioning itself as one of the leading suppliers of feed additives to the animal protein value chain, with many years of experience developing and producing vitamins, carotenoids, enzymes, and organic acids for the feed industry, alongside increasingly digital solutions for sustainable production. Its core strength is vertically integrated vitamin manufacturing, few competitors can match BASF’s raw-material-to-finished-product control in this category.
Portfolio & Relevance
The company’s flagship Lutavit® vitamin line remains central to its identity, produced at what it describes as the world’s largest vitamin A formulation facility, leveraging advanced resource efficiency and lower-carbon energy sources and raw materials. Its broader animal nutrition portfolio spans vitamins, carotenoids, enzymes, and organic acids tailored to species-specific needs across livestock, aquaculture, and companion animals.
Recent Development (2025)
BASF’s animal nutrition unit has been actively reshaping its portfolio rather than expanding broadly. In October 2025, it launched Lutavit® A/D3 1000/200 NXT, a next-generation vitamin formulation combining vitamin A and vitamin D3 in a single microencapsulated form, manufactured at its Verbund site in Ludwigshafen, described as marking BASF’s “return to the market” in this specific product category. At the same time, the company has been divesting non-core lines: in November 2025, it reached a binding agreement for Biochem to acquire BASF’s global glycinate business, covering organic trace minerals, and separately announced it is exploring strategic options for its feed enzyme business, part of a broader industry trend (alongside DSM-Firmenich and others) of large chemical groups narrowing focus toward core, vertically-integrated ingredient categories rather than the full additive spectrum
11. Adisseo (Animal Nutrition)
Category: Feed Additive & Amino Acid Specialist
Quick Facts
- Founded: 1939 (France)
- Headquarters: Antony, Île-de-France, France
- Total Employees: More than 3,000 employees representing 60 nationalities
- Ownership: Public, listed on the Shanghai Stock Exchange (600299); one of the main subsidiaries of China National BlueStar, itself part of Sinochem’s life sciences segment
- Species/Segment Focus: Poultry, swine, ruminant, aquaculture, methionine and amino acids, vitamins, enzymes, phytogenics, palatability and specialty additives
Overview
Adisseo positions itself as one of the world’s leading feed additive experts, among the world leaders in animal nutrition & health with turnover above €2 billion and over 4,200 customers. Originated from France and now rooted in China, the company describes itself as benefiting from an integrated “WE” culture combining Western and Eastern business practices, having joined the Bluestar group roughly two decades ago, facilitating access to the Chinese market. Its core strength is vertically integrated methionine manufacturing at global scale, paired with a long-standing vitamin and specialties business.
Portfolio & Relevance
Adisseo’s flagship position is in methionine, where it is among the few manufacturers able to produce liquid and solid methionine simultaneously, and owns a fully vertically integrated production process for liquid methionine, marketed under the Rhodimet and Smartamine/MetaSmart (rumen-protected) lines. Its broader portfolio spans vitamins (Microvit), feed enzymes, phytogenics (via Norfeed), palatability solutions, and digital/precision nutrition services, serving poultry, swine, ruminant, and aquaculture segments.
Recent Development (2025–2026)
Adisseo has been aggressively expanding methionine capacity while its specialties business also gained share. In 2025, Adisseo recorded double-digit year-over-year revenue growth (+11%, CNY17.23 billion), with gross profit up 4% to CNY4.88 billion, as methionine sales hit a new record for liquid methionine volume on continuous global penetration, while the specialties business grew 10% year-over-year, led by a 20% increase in Smartamine ruminant sales and strong growth from Norfeed’s phytogenics line. On the capacity side, the new 150,000-ton powder methionine plant in Quanzhou, China is over 80% built and targeting trial operation by the end of 2026, while a 40,000-ton debottlenecking project at its European liquid methionine plant in Burgos, Spain is now fully operational. Adisseo’s methionine business director has pointed to rising poultry and swine production, along with feed formulators’ shift toward higher methionine inclusion rates, as the key demand drivers behind this expansion, with 2026 poultry industry growth projected at around 2.5% versus 2025.
Let me know if you’d like me to pull in the company’s LinkedIn-style facts (research center count, customer count trends) or trim this to match BASF’s exact word count more precisely.
12. Kemin Industries (Animal Nutrition)
Category: Feed Additive & Ingredient Specialist
Quick Facts
- Founded: 1961, Des Moines, Iowa, USA (by R.W. and Mary Nelson)
- Headquarters: Des Moines, Iowa, USA
- Total Employees: More than 3,000 employees worldwide
- Ownership: Private, family-owned and operated, led today by the second and third generations of the Nelson family, including Dr. Chris Nelson (President and CEO) and Libby Nelson (Vice President)
- Species/Segment Focus: Poultry, swine, beef, dairy, aquaculture, companion animal, antioxidants, mold inhibitors, toxin binders, enzymes, probiotics, carotenoids, palatants, and animal vaccines
Overview
Kemin describes itself as a global leader in the ingredient manufacturing industry producing more than 500 specialty ingredients across six continents, employing thousands of team members and serving more than 120 countries. It positions itself as a trusted market leader in the animal feed, beef, dairy, poultry, and pig industries, focused on developing nutritional ingredients such as probiotics, immune supplements, and mycotoxin solutions that help producers raise healthy livestock. Unlike its larger vitamin- and amino-acid-focused peers, Kemin’s core strength lies in specialty, application-specific ingredients — antioxidants, mold inhibitors, and gut-health/pathogen-control solutions — backed by proprietary encapsulation and coating technologies developed in-house.
Portfolio & Relevance
Kemin’s animal nutrition portfolio centers on well-established branded lines including CholiPEARL, Clostat, Ammo CURB, ButiPEARL, Endox, Fortium, Naturox, Palasurance, Paramega, and Fortra, spanning antioxidant formulations, natural extracts, liquid antimicrobials, forage preservatives, toxin binders, enzymes, probiotics, and carotenoids. Kemin’s solutions aim to strengthen safety throughout various stages of the food chain, improve animal nutrition through enhanced ingredient utilization, and support overall animal health, backed by dedicated technical service, application engineering, and customer laboratory teams. The company also operates Kemin Biologics, providing customized animal vaccine solutions, and Kemin AquaScience for fish feed and premix.
Recent Development (2025)
Kemin has been expanding its enzyme and animal-health capabilities through acquisition. In September 2025, Kemin acquired CJ Youtell Biotech, the enzymes and fermentation subsidiary of CJ Bio, gaining full ownership of CJ Youtell’s fermentation plants and enzyme product portfolio, including strategically located plants in Shandong and Hunan, China. Kemin’s Enzymes president noted the deal enables a fully integrated enzyme offering, from proprietary strain development and manufacturing through to final formulation and application support, while the new Chinese facilities bring specialized laboratories and technical teams in bioengineering, biochemistry, and enzyme formulation to support R&D. The month prior, in August 2025, Kemin acquired Hennessy Research Associates, a Lenexa, Kansas-based contract research and vaccine manufacturing organization, adding vaccine R&D, biological manufacturing, and CRO/CDMO/CMO capabilities along with more than 50 tenured scientists to its Kemin Biologics animal vaccine business. Together, the deals reflect Kemin’s strategy of building out adjacent, higher-value capabilities (enzymes, biologics/vaccines) around its core specialty-ingredient franchise, rather than pursuing the vitamin/amino-acid consolidation trend seen among BASF and Adisseo.
13. Novus International (Animal Nutrition)
Category: Feed Additive & Ingredient Specialist
Quick Facts
- Founded: 1991, St. Louis, Missouri (from Monsanto’s MHA/ALIMET feed additive businesses)
- Headquarters: Chesterfield/St. Charles, Missouri, USA
- Total Employees: Approximately 773 employees globally
- Ownership: Private, wholly owned by Mitsui & Co. and Nippon Soda Co., Ltd.
- Species/Segment Focus: Poultry, swine, dairy/ruminant, aquaculture, methionine, organic trace minerals, enzymes, organic acids, essential oils
Overview
NOVUS positions itself as an “intelligent nutrition” company that combines global scientific research with local insights to develop advanced technology helping protein producers achieve better results. NOVUS describes itself as a global leader in health and nutrition solutions for the animal agriculture industry, with roots tracing back to Monsanto’s pioneering methionine hydroxy analogue (MHA) research beginning in the 1950s. Its core strength has historically centered on liquid methionine technology and bis-chelated organic trace minerals, complemented by proprietary encapsulation science.
Portfolio & Relevance
NOVUS’s product portfolio includes amino acids, organic bis-chelated trace minerals, organic acids, enzymes, essential oils, and its groundbreaking INTERIUS™ technology for embedding functional ingredients directly in grain. Flagship brands include ALIMET and MINTREX (bis-chelated trace minerals), alongside enzyme products such as CIBENZA. The company provides products and solutions across transition, early lactation, mid-lactation, late lactation, and replacement-heifer markets for dairy, alongside dedicated poultry and swine research programs, backed by a global technical services and applied research organization.
Recent Development (2025)
NOVUS undertook a major structural realignment in 2025 to sharpen its strategic focus. In June 2025, the company announced a strategic business realignment splitting into two separate business units under the NOVUS umbrella, one dedicated to liquid methionine solutions and the other focused exclusively on specialty feed ingredients, each structured as an independent platform with dedicated profit-and-loss accountability. CEO Dan Meagher continues to lead the parent organization with strategic oversight across both businesses, while Dave Dowell was appointed president of the methionine unit and Ed Galo president of the specialty ingredients unit. Meagher described the move as “not a division – it’s an evolution,” intended to let each unit “innovate faster, respond smarter” for producers globally. The realignment mirrors the broader industry pattern also seen at BASF and Adisseo, separating commodity-scale amino acid manufacturing from higher-margin specialty ingredient innovation. Separately, in November 2025, NOVUS unveiled refreshed product logos and packaging as part of a broader rebranding initiative aimed at improving visibility and brand cohesion across its diverse customer base of nutritionists, producers, and distributors
14. Alltech (Animal Nutrition)
Category: Feed Additive & Nutrition/Biotechnology Specialist
Quick Facts
- Founded: 1980, Lexington, Kentucky (by Dr. Pearse Lyons)
- Headquarters: Nicholasville, Kentucky, USA
- Total Employees: More than 5,000 employees worldwide
- Ownership: Private, family-owned, a private, family-owned company led by Dr. Mark Lyons (President & CEO)
- Species/Segment Focus: Dairy, beef, poultry, swine, aquaculture, equine, companion animal — yeast-based technologies, organic trace minerals, mycotoxin management, phytogenics, crop science, and commercial feed
Overview
Alltech describes itself as a global leader in animal nutrition and agricultural biotechnology, delivering innovative, sustainable solutions for plant and animal health across more than 140 countries, operating more than 75 manufacturing facilities and five bioscience centers worldwide. Founded by Irish biochemist Pearse Lyons on the strength of yeast fermentation science, the company’s core differentiator is its nutrigenomics and yeast-culture technology platform (Yea-Sacc, launched in 1983), which underpins its “natural nutrition” positioning relative to synthetic-additive competitors. Alltech operates across three main divisions, animal nutrition and health, crop science, and food and beverage, reflecting a broader diversification than most pure-play feed additive peers.
Portfolio & Relevance
Alltech’s animal nutrition portfolio centers on specialty ingredients, premix supplements, feed and biologicals, supported by a platform of science-based services, spanning yeast-based additives, organic trace minerals, gut-health and mycotoxin-risk-reduction programs, and phytogenics. Beyond core ingredients, Alltech owns significant commercial feed operations through subsidiaries such as Hubbard Feeds (US) and Masterfeeds (Canada), giving it a rare combination of specialty-ingredient science and commodity-scale feed manufacturing among the companies profiled here. Recent launches include Olerix, a phytogenic blend for pigs designed with a proprietary coating process to outlast digestion, alongside the REVELEX anaerobic digestion solutions range.
Recent Development (2025–2026)
Alltech’s most significant recent move has been consolidating its North American commercial feed business rather than expanding its specialty-ingredient science. In September 2025, ADM and Alltech signed a definitive agreement to launch a North American animal feed joint venture, with Alltech contributing its U.S.-based Hubbard Feeds and Canada-based Masterfeeds businesses (18 U.S. feed mills and 15 Canadian mills) and ADM contributing its 11 U.S. feed mills; the venture would be majority-owned by Alltech with a board evenly split between the two parents. The venture, named Akralos Animal Nutrition, officially launched February 1, 2026, operating more than 40 feed mills across North America and supported by more than 1,400 team members, under CEO Brian Gier. The partnership combines more than 160 years of combined expertise to deliver advanced feed solutions for livestock, equine, and specialty animal markets, with Hubbard and Masterfeeds retained as customer-facing brands. The deal reflects a different consolidation logic than BASF, Adisseo, or Novus’s vitamin/methionine-focused divestitures, Alltech is instead scaling its commodity feed-manufacturing footprint through partnership while keeping its specialty-ingredient science wholly owned
15. Lallemand (Animal Nutrition)
Category: Microbial Solutions Specialist (Yeast & Bacteria)
Quick Facts
- Founded: 1895/1915, Montreal, Canada (by Fred Lallemand; production plant built 1915)
- Headquarters: Montreal, Quebec, Canada (Lallemand Animal Nutrition division based in Toulouse, France / Milwaukee, Wisconsin)
- Total Employees: Roughly 5,500 employees across more than 50 production facilities worldwide
- Ownership: Private, family-owned, a privately held global company headquartered in Canada, owned by the Chagnon family since 1952, led by CEO Antoine Chagnon
- Species/Segment Focus: Ruminant, swine, poultry, aquaculture, equine, companion animal, live yeast and bacteria probiotics, silage inoculants, yeast derivatives, natural antioxidants
Overview
Lallemand distinguishes itself among feed additive players as a pure-play microbiology company rather than a chemical manufacturer. Its microbiology expertise traces back to 1862 in Germany, with the company itself founded in Montreal at the end of the 19th century and later transformed by the Chagnon family in 1952 from a baker’s yeast producer into a major player in the development and production of specific yeast and bacteria strains across markets including baking, brewing, oenology, and animal nutrition. Lallemand Animal Nutrition, one of the company’s core business units, is committed to optimizing animal performance and wellbeing with specific microbial product and service solutions, describing itself as a “field-led, science supported” company with solutions marketed in over 80 countries.
Portfolio & Relevance
Lallemand Animal Nutrition develops, produces and markets silage additives, probiotics, antioxidants and yeast derivatives for animal nutrition, as well as microbial solutions for animal environment, serving all livestock markets: ruminant, swine, poultry, aquaculture as well as equine and companion animals. Flagship brands include LEVUCELL® SC (live yeast probiotic), PROTERNATIVE®, and MAGNIVA® Forage Inoculants, alongside a broader range of yeast and bacteria probiotics, natural antioxidants, and plant extracts. Unlike BASF, Adisseo, or Novus, Lallemand’s competitive edge rests entirely on proprietary microbial strain collections and fermentation science rather than synthetic chemistry.
Recent Development (2025)
Lallemand has been aggressively consolidating the fragmented enzyme and fermentation ingredient space through its Lallemand Bio-Ingredients unit, extending capabilities that also feed into its animal nutrition business. In June 2025, Lallemand completed the acquisition of AIT Ingredients, a global producer of baking ingredients with technical and creative solutions across the bakery, flour milling, and pasta industries, following exclusive negotiations with Moulins Soufflet, a subsidiary of Groupe InVivo. The following month, Lallemand Bio-Ingredients completed the acquisition of Solyve, a French producer of GMO-free and organic enzyme solutions for use across the oenology, fruit juices, baking, plant-based beverage, and animal nutrition sectors. Lallemand Bio-Ingredients president Lars Asferg noted the deal brings a complementary set of capabilities to the unit’s rapidly expanding enzyme business. These moves followed a similar pattern of prior acquisitions of Swiss biotech firm Evolva and an equity stake in Turkey’s Livzym Biotechnologies, and most recently the completed purchase of US enzyme producer BIO-CAT Enzymes & Microbials, with CEO Antoine Chagnon noting the deal reinforces Lallemand’s presence in health ingredient markets and expands its US production footprint to better serve customers “across the global animal nutrition, agriculture and food industries.” Together, these deals position Lallemand to bring expanded enzyme and fermentation technology directly into its animal nutrition portfolio, complementing its established yeast and bacteria probiotic base.
16. Novonesis (Animal Nutrition)
Category: Enzyme & Microbial Biosolutions Specialist
Quick Facts
- Founded: 2024 (through merger of Novozymes, founded 1925/2000, and Chr. Hansen, founded 1874)
- Headquarters: Lyngby, Denmark (Chr. Hansen legacy site: Hørsholm; Novozymes legacy site: Bagsværd)
- Total Employees: Approximately 11,889 employees worldwide as of 2026
- Ownership: Public, controlled by Novo Holdings, the investment arm of the Novo Nordisk Foundation, listed on Nasdaq Copenhagen (NSIS B)
- Species/Segment Focus: Poultry, swine, ruminant/dairy, aquaculture, companion animal, feed enzymes, probiotics, silage inoculants, microbial biosolutions
Overview
Novonesis positions itself as the world leader in industrial enzymes and microbial solutions, holding a nearly 50% market share in both categories, formed through a combination of Chr. Hansen and Novozymes in January 2024. The company generates 35.8% of net sales from the agriculture, bioenergy and animal feed industries, its largest single segment. Its core differentiator is unmatched biological scale: Novonesis leverages a vast library of over 50,000 microbial strains and 10,000+ patents across two divisions, Food & Health Biosolutions and Planetary Health Biosolutions, giving it deeper fermentation and strain-engineering capability than any single-species-focused competitor.
Portfolio & Relevance
Novonesis’s animal nutrition portfolio spans enzymes, probiotics, microbes, and silage inoculants that work in synergy to drive consistent results in sustainable animal farming, covering poultry, swine, ruminant, aquaculture, and companion animal segments. Key products include gut-health solution Balancius, phytase platform HiPhorius, protease enzyme ProAct 360, and probiotic lines built on the legacy Chr. Hansen bacteria collection. Enzymes help unlock more from feed while probiotics support microbiome robustness and normal digestive health, positioning Novonesis as a science-and-scale supplier to feed formulators rather than a full premix or vitamin manufacturer.
Recent Development (2025–2026)
Novonesis significantly consolidated its position in the animal feed enzyme market in late 2025. Novonesis acquired dsm-firmenich’s share of the Feed Enzyme Alliance following 25 years of partnership, bringing sales, distribution, research, and innovation together under one roof for the first time. The company explained that it developed and produced the feed enzyme products while dsm-firmenich handled sales, support, and distribution for over 25 years, and with the acquisition, Novonesis now assumes full responsibility for providing existing feed enzymes while investing in new products. The move strengthens Novonesis’s position in the global animal nutrition sector, with plans to focus on combining enzymes and probiotics to improve poultry performance, health, and welfare, directly competing with BASF and Adisseo’s integrated additive models. On the product side, in April 2026 Novonesis launched Bovacillus™, a feed-stable Bacillus probiotic to improve health and productivity in dairy cattle, described as Europe’s first Bacillus probiotic designed specifically for lactating dairy cows, supported by 9 peer-reviewed publications, 12 mode-of-action studies, and 5 years of field data. Financially, Novonesis reported 5% organic sales growth in Q1 2026, with growth partly driven by inventory build-up in the Animal segment.
17. Balchem Corporation (Animal Nutrition & Health)
Category: Choline & Chelated Mineral / Encapsulation Specialist
Quick Facts
- Founded: 1967, New Hampton/New York, USA
- Headquarters: Montvale, New Jersey, USA
- Total Employees: Approximately 1,400 employees worldwide across the whole corporation
- Ownership: Public listed on NASDAQ (BCPC)
- Species/Segment Focus: Ruminant, swine, poultry, aquaculture, companion animal, choline, chelated minerals, encapsulated/rumen-bypass nutrients, niacin, amino acids
Overview
Balchem is a diversified specialty ingredients company operating three segments, Human Nutrition & Health, Animal Nutrition & Health (ANH), and Specialty Products, with ANH positioned as the global leader in choline production, mineral chelation and encapsulation technology for rumen bypass nutrients. Unlike the vitamin- or amino-acid-scale players (BASF, Adisseo, Novus), Balchem’s competitive moat is narrower but deeper: proprietary microencapsulation and chelation platforms applied almost exclusively to choline and trace minerals. The company crossed $1 billion in revenue for the first time in 2025 with record earnings, reflecting steady growth across its diversified ingredient portfolio.
Portfolio & Relevance
Balchem ANH’s flagship technology is precision-release choline: REASHURE Choline, an encapsulated choline product that improves health and production in transition and early lactating dairy cows, alongside NITROSHURE, an encapsulated urea supplement, and NIASHURE, a microencapsulated niacin product to help fight heat stress in animals. Its monogastric-focused PuraChol line is the leading line of choline chloride products available in the industry, delivering the highest standards of quality backed by the strictest process controls. The ANH segment provides a global leader position in choline production, nutrient encapsulation, chelated minerals, and functional ingredients, serving ruminants, swine, poultry, aquaculture, and companion animals via brands including KeyShure (chelated minerals) and AminoShure (rumen-protected amino acids).
Recent Development (2025–2026)
Balchem’s ANH business has focused on brand consolidation and pricing discipline amid volatile input costs rather than major M&A. In early 2026, Balchem Animal Nutrition & Health launched an updated Purachol Choline Chloride line, continuing to build on its position as choline category leader. More significantly, in May 2026 Balchem implemented a global price increase across its entire Animal Nutrition and Health product portfolio, including Choline Chloride and micro-encapsulated amino acids, effective April 15, citing ongoing geopolitical conflicts in the Middle East that drove volatility across global markets, higher energy and raw material costs, and freight disruption impacting production economics across the animal nutrition industry. On the growth side, industry analysts note Balchem is pursuing acquisitions in animal nutrition focused on precision-release technologies for ruminants to support sustainable dairy production in South America, extending its core rumen-bypass/encapsulation expertise into new geographies rather than diversifying into vitamins or enzymes. This positions Balchem as a narrower, margin-focused specialist compared to the broader consolidation moves seen at BASF, Adisseo, and Novonesis.
18. IFF – Danisco Animal Nutrition & Health (Animal Nutrition)
Category: Feed Enzyme & Gut Health Specialist
Quick Facts
- Founded: Danisco Animal Nutrition traces to Danisco (1989 merger) and Genencor’s enzyme heritage; folded into DuPont Nutrition & Biosciences, then IFF via 2021 merger. IFF itself dates to 1889/1958 (Polak & Schwarz / van Ameringen-Haebler merger)
- Headquarters: Danisco Animal Nutrition & Health Leiden, Netherlands; parent IFF — New York City, USA
- Total Employees: IFF group approximately 22,400 employees (2024); Animal Nutrition & Health is a business unit within IFF’s Health & Biosciences segment, not separately disclosed
- Ownership: Public IFF trades on NYSE (IFF), S&P 500 component
- Species/Segment Focus: Poultry, swine, ruminant, aquaculture feed enzymes, betaine, phytogenics, probiotics
Overview
Danisco Animal Nutrition & Health sits inside IFF’s Health & Biosciences segment, positioned as an industry leader in nutritional health solutions with a comprehensive portfolio of feed enzymes, betaine, phytogenics and probiotics. Its scientific credibility rests on unusually deep gut-microbiome research: capabilities are underpinned by the quality and quantity of trials, including over 80,000 guts sampled from over 500 farms, investments in omics technologies and microbiome research, and collaboration with leading commercial, governmental and academic partners. The business frames its work through the lens of “nutribiosis” investing in science and innovation to help producers improve performance, increase liveability and support welfare amid increasing pressure to reduce or remove antibiotics from production systems. Parent IFF itself is the largest specialty ingredients producer globally, with its health and biosciences business generating roughly 30% of profits and holding a global leadership position in probiotics and enzymes.
Portfolio & Relevance
The Danisco Animal Nutrition & Health portfolio spans over 40 years of feed enzymes and gut health solutions that have helped livestock producers resolve nutritional and health challenges at the heart of antibiotic-free and sustainable production, including landmark products like Phyzyme XP, the world’s first E. coli phytase, and the Syncra AVI enzyme/probiotic combination. The ruminant line includes Bovizyme GA (an enzyme solution improving starch digestion efficiency for non-steam flaker feed yards), Omni-Bos probiotics, and Betafin natural betaine. The business also offers data-driven services including detailed raw material and feed ingredient analyses to help producers determine accurate phytase dosage and improve profitability.
Recent Development (2025–2026)
Unlike its peers, IFF’s Animal Nutrition unit is not undergoing divestiture and instead posted steady growth as IFF streamlines its broader portfolio elsewhere. In Q2 2026, IFF’s Health & Biosciences segment sales grew 5% to $601 million, with notable increases specifically in grain processing, food biosciences, and animal nutrition, while segment EBITDA increased 6% to $150 million, primarily due to volume leverage. Management highlighted continued growth opportunities in the broader Health & Biosciences area, including probiotics and GLP-1-related products, while IFF has been aggressively divesting unrelated segments, agreeing in May 2026 to sell its Food Ingredients business to CVC Capital Partners for nearly $4.3 billion, to sharpen its focus on higher-growth, higher-margin segments like Health & Biosciences, which houses Animal Nutrition. This stands in sharp contrast to the broader industry: while DSM-Firmenich sold its entire Animal Nutrition & Health business to CVC for €2.2 billion in February 2026 and Adisseo, BASF, and Novus have been reshaping or divesting commodity lines, IFF has kept and grown its animal nutrition enzyme and probiotic business as a retained strategic asset within its restructured portfolio.
19. AB Vista (AB Agri) — Animal Nutrition
Category: Feed Enzyme & Gut Health Technology Specialist
Quick Facts
- Founded: 2004, United Kingdom
- Headquarters: Marlborough, Wiltshire, UK
- Total Employees: Approximately 208 employees across five continents
- Ownership: Private, a subsidiary of AB Agri, the agricultural division of Associated British Foods (ABF plc), one of Europe’s largest food & retail companies with a market capitalisation of £25 billion
- Species/Segment Focus: Poultry, swine, ruminant, aquaculture, feed enzymes (phytase, xylanase), natural betaine, stimbiotics, gut microbiome, vitamin D metabolites
Overview
AB Vista is a focused animal nutrition technology company that, since its establishment in 2004, has grown to be a top-three player in feed enzymes and is also one of the largest suppliers of natural betaine to the global animal nutrition industry. Unlike the larger diversified players in this report, AB Vista operates a deliberately narrow, science-first model: its distinguishing traits are a pioneering spirit and a non-conformist approach to innovation, all underpinned by the integrity at the heart of its feed services and additives business. The company invests heavily in R&D and academic partnerships, positioning itself as the technical-insight specialist within AB Agri’s broader agricultural portfolio rather than a bulk commodity manufacturer.
Portfolio & Relevance
AB Vista’s core technology platform centers on its Maximum Matrix Nutrition enzyme strategy, which capitalises on the properties of Quantum Blue, an enhanced E. coli phytase with a high affinity for phytate, alongside Econase XT, a thermostable and inhibitor-resistant xylanase. Its gut-health portfolio includes Signis, a Stimbiotic functional feed additive that accelerates development of a fibre-degrading microbiome, and Vistabet, a natural betaine source that helps preserve gut integrity, improve carcass quality, and spare choline and methionine inclusion. The company also operates an extensive NIR (near-infrared) analytical services network and dedicated feed-testing laboratories to support precision nutrition.
Recent Development (2025–2026)
AB Vista has focused on product line expansion and lab infrastructure investment rather than M&A. At IPPE in January 2026, the company highlighted Ultra-25 D, a 25-hydroxy vitamin D₃ source and metabolite of vitamin D offering higher bioavailability than traditional vitamin D₃, allowing producers to use less while maintaining performance, in poultry, ensuring faster biological response, improved muscle performance, stronger bones, enhanced eggshell quality, and boosted immune response during stress periods. The company noted that when combined with its Quantum Blue phytase, Ultra-25 D provides ideal mineral balance for animals. AB Vista also strengthened its technical credibility infrastructure, announcing that its laboratories in the UK and US achieved ISO/IEC 17025:2017 accreditation, the internationally recognised benchmark for technical competence in testing and calibration. Looking ahead, the company plans to showcase two new enzyme blends developed specifically for the growing Chinese market at China Feed Industry Expo 2026, reflecting continued geographic expansion into Asia-Pacific alongside its established European and North American base, a more incremental, innovation-led growth pattern compared to the major M&A and divestiture activity seen at BASF, Adisseo, Novus, and dsm-firmenich/IFF.
20. Godrej Agrovet (Animal Nutrition)
Category: Diversified Agribusiness & Compound Feed Manufacturer
Quick Facts
- Founded: 1991, incorporated as Godrej Agrovet Private Limited; animal feed business launched 1992
- Headquarters: Mumbai, Maharashtra, India
- Total Employees: 6,536 total employees
- Ownership: Public — listed on BSE (540743) and NSE (GODREJAGRO); majority-owned by Godrej Industries Group (GIG), the primary listed holding vehicle for the Godrej family’s non-consumer and industrial businesses following a May 2024 restructuring, holding approximately 52-55% of equity
- Species/Segment Focus: Cattle (dairy), poultry (broiler/layer), aquaculture (shrimp/fish), compound feed, specialty feed, on-farm technical services; primarily India and Bangladesh
Overview
Godrej Agrovet stands apart from the other companies in this report as a diversified, India-focused agribusiness rather than a pure feed-additive or ingredient specialist. The company operates across key segments including Animal Nutrition, Crop Care, Dairy, Food, and Oil Palm, and holds leadership positions in several categories, including being India’s largest producer of crude palm oil and a leading player in the animal feed industry. Its Animal Nutrition business is the group’s largest revenue driver, contributing 46% of FY26 revenue, and the company is among India’s largest organised animal feed manufacturers, offering a diversified portfolio of cattle, layer, broiler, shrimp, fish and other animal feed products, including a Bangladesh presence through its joint venture, ACI Godrej Agrovet Pvt Ltd.
Portfolio & Relevance
Rather than manufacturing specialty additives, Godrej Agrovet’s core strength is compound feed manufacturing at national scale: the company operates a widespread manufacturing network with over 60 production facilities across India, offering cattle feed, poultry feed, aqua feed, and specialty animal nutrition solutions backed by on-farm technical support. It also holds a controlling stake in Creamline Dairy Products (Godrej Jersey brand) and a poultry joint venture with Tyson Foods (Real Good Chicken, Yummiez). Unlike BASF, Adisseo, or AB Vista, Godrej Agrovet sits downstream in the value chain, closer to feed production and farmer-facing distribution than upstream ingredient science.
Recent Development (2025–2026)
Godrej Agrovet’s animal nutrition business has been the standout performer amid a broader company-wide strategic simplification. Animal nutrition revenue grew 12.6% year-over-year, with 15% cattle feed volume growth and segment results up 29%, while the Bangladesh JV delivered double-digit growth in volume, revenue, and PBT. To support this momentum, the company announced plans in mid-2025 to set up a new feed plant in Maharashtra state with an initial investment of Rs 110 crore, and management is guiding early double-digit revenue growth for the animal nutrition business in FY27, with broad-based volume growth and geographic expansion into Central and East India still in early stages. This growth push comes alongside a broader portfolio reset: management has identified branded foods, oil palm, crop care, and cattle feed as priority growth pillars, while “rebooting” Astec LifeSciences, ACI Godrej, and Creamline Dairy, closing its Live Bird Trading business entirely, and strategically reviewing its Shrimp Feed business, a shift the company describes as moving away from a “commodity mindset” toward “multiple pillars of growth.” This positions Godrej Agrovet as pursuing capacity-led organic growth in its core animal feed business while simplifying its broader conglomerate structure, a notably different strategy from the ingredient-science consolidation seen among BASF, Adisseo, and dsm-firmenich
Methodology: Popularity & Relevance Criteria
This list ranks companies by popularity and industry relevance rather than disclosed revenue, reflecting how visibly and actively each company shapes conversation in the animal nutrition space today. Companies were evaluated against six criteria:
- Industry visibility — frequency of coverage in trade press (Feed Strategy, WATT Global Media, AllAboutFeed, AgriBusiness Global) and presence at major industry events (VIV, IPPE, Alltech ONE, EuroTier)
- Portfolio breadth — range across species (poultry, swine, ruminant, aquaculture, companion animal) and product categories (premixes, enzymes, probiotics, amino acids, mycotoxin management, specialty additives)
- Global footprint — scale of international manufacturing, distribution, and R&D presence across multiple continents
- Innovation signal — frequency and substance of recent product launches, partnerships, and R&D announcements (2024–2026), used as a proxy for current market relevance
- Sustainability and regulatory relevance — active involvement in antibiotic-alternative solutions, low-carbon feed strategies, or novel protein sources, reflecting the industry’s dominant strategic themes
- Corporate scale and strategic activity — significant M&A, joint ventures, or parent-company backing that signals staying power and market weight, even where standalone financials aren’t disclosed
